Home

Douglas Kerr, Chief Medical Officer: Dyne Therapeutics DYN Sell · Filed 05/14

Trade details

Type
Insider sale
Amount
$28,715.04
Shares · price
1,564 sh · $18.36 a share
Held after
170,042 sh
Trade date
26/05/13
Filed
26/05/14
Days to filing
1 days

Sold 0.9% of holdings

Share of holding sold
0.9%

Dyne Therapeutics trades, last 26 weeks

What else happened in Dyne Therapeutics around then

Filed or reported within 30 days of the trade day · 04/13~06/12

Douglas Kerr's recent trades

  • Douglas Kerr

    Planned saleDyne Therapeutics

    $661

    Filed 09/08

  • Douglas Kerr

    Planned saleDyne Therapeutics

    $121.7K

    Filed 09/04

  • Douglas Kerr

    Planned saleDyne Therapeutics

    $64.2K

    Filed 08/13

  • Douglas Kerr

    Sell10b5-1 planDyne Therapeutics

    $16.3K

    Filed 06/17

  • Douglas Kerr

    Sell10b5-1 planDyne Therapeutics

    $13.5K

    Filed 03/06

Douglas Kerr, Chief Officer — sold $28.7K of Dyne Therapeutics DYN · 0.9% of holdings · 10b5-1 plan | Whalegun